Responses
Immunotherapy biomarkers
Original research
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
